原发性胆汁性胆管炎(PBC)又称原发性胆汁性肝硬化,约90%的患者为女性,如果不及时治疗将会导致肝硬化。
此次认定是基于一项随机、双盲、安慰剂对照、为期12周的Ⅱ期临床试验数据,研究目的是...查看全文
牛唐2019-03-11 17:14
NASH领域又有新的IPO公司,而且研发管线都是处于后期,$Genfit(GNFT)$ 的Elafibranor处于临床三期,计划四季度公布topline,且有FT认证,但之前公布的数据不太理想,$Cirius Therapeutics(CSTX)$ 的MSDC-0602K处于临床二期,下半年计划公布topline查看全文
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003861 Act: 34 Size: 254 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003476 Act: 34 Size: 95 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003373 Act: 34 Size: 108 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003152 Act: 34 Size: 90 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003049 Act: 34 Size: 67 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002860 Act: 34 Size: 85 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002242 Act: 34 Size: 82 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002021 Act: 34 Size: 253 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-001868 Act: 34 Size: 58 KB 网页链接
$Genfit(GNFT)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001757064-24-000007 Act: 34 Size: 40 MB 网页链接